# PIPERACILLIN AND TAZOBACTAM
> **ANDA208675** · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS INC · Approved 2021-02-16
## Drug
- **FDA Application Number:** ANDA208675
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PIPERACILLIN AND TAZOBACTAM
- **Generic name:** PIPERACILLIN SODIUM, TAZOBACTAM SODIUM
- **Active ingredients:** PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** SAGENT PHARMS INC
- **Manufacturer:** Sagent Pharmaceuticals
- **First approval:** 2021-02-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208675)
---
*AI Analytics · CC0 1.0*